2024參展單位列表
關鍵字搜尋
想找產品或是與參展商洽談?!點此前往 Healthcare+ B2B 全球醫療採購網→→→

LifeSenz Cancer Research Labs Pvt Ltd

LifeSenz Cancer Research Labs (www.lifesenz.co.in) is a biomedical R&D based company. We are ISO 9001:2015 certified with startup India (DIPP 103053), local FDA approved and National Skill Development Corporation, India (LSSSDC) affiliated company. LifeSenz is working in three domains: 1. Personalized cancer therapy prediction model: Therapy prediction is a challenge in cancer and considering both time and money is critical for cancer management, LifeSenz has developed a patient biopsy derived ex vivo based 3D cancer model (mimicking in vivo physiology) which can predict therapeutic drug efficacy before the clinical treatment begins; thereby it can reduce the effective treatment cost, minimize non-effective treatment mediated side effects but also improve therapeutic efficacy. At present LifeSenz is processing the clinical validation study with various channel partners across India. 2. Translational Research: Both In house and collaborative research as well as consultancy/servicebased research engagements helps us to better understand the unmet challenges of various metabolic diseases such as cancer, osteoarthritis etc but also assist us to identify better drug development or identification. In this regard LifeSenz already collaborates with multiple research partners (academia/ industry) across India and provides scientific services to the community. 3. Scientific Training and Development: Utilizing current laboratory infrastructure, LifeSenz is currently engaged to train and upskills biopharma students (under/postgrads/PhD in any stream of LifeSciences) through various short and long-term research-based industry relevant technical training programs. In this regard LifeSenz already in collaboration with multiple research based institutions across India and provides industry relevant technical training and services to the community. Thereby it is contributing in generating future ready high skilled human resources for global biopharma entities.

中央研究院生醫轉譯研究中心

今年將以國家生技研究園區進駐廠商的量能與成果為展出重點,並設有洽談區,進入展區即可有輕鬆交流的場域。另外規劃舞台設計,將安排園區相關單位與進駐廠商發表論壇演講,讓專業人士與一般民眾更了解園區的單位與廠商。

國家科學及技術委員會新竹科學園區管理局

新竹科學園區轄屬六個衛星園區,分別是新竹、竹南、銅鑼、龍潭、宜蘭與新竹生物醫學園區等科學園區,總開發面積1,375公頃,目前所有衛星學園區已有廠商進駐並開始營運。截至目前,核准廠商數已經超過600家,員工超過16萬人,近年平均營業額均突破兆元。園區產業共分六大類:積體電路產業、電腦及周邊產業、通訊產業、光電產業、精密機械產業及生物技術產業。其中積體電路產業之產值佔園區總產值達7成,為園區第一大產業,光電產業營業額佔園區總產值近2成,為園區第二大產業;餘為精密機械產業、電腦及周邊產業,通訊產業及生物技術產業等。

惠民製藥股份有限公司

惠民製藥成立於西元1962年,以成功研發優碘系列藥品並廣為各大教學醫院指定使用而知名。近年來更拓寬代理國際嚴選優質安心的原料品牌,包含賦形劑、化妝品、保健機能食品、醫美保養品等。提供原料專利資訊、產品概念、配方設計、技術諮詢等服務,滿足國內外產業界多元的開發需求。
此次展出巴斯夫BASF, 伊士曼Eastman, 富士化學FujiChem, 信越化學ShinEstu...等國際頂級藥品原料: API、Kollidon、直打系列.充填賦形劑、水性膜衣、腸溶膜衣、增溶乳化劑、軟化劑.潤膚劑.保濕劑、色素、增稠劑.緩試劑型、抗結劑/潤滑劑、溶劑.增塑劑、崩散劑...

洛科儀器股份有限公司

切向流過濾系統 Tanfil 100,濃縮滲濾一次搞定!
◆ 適用於各種生化處理
◆ DNA/RNA濃縮、生物分子分離、病毒移除
◆ 減少常見的濾膜堵塞問題,濾膜壽命更長更久

藥華醫藥股份有限公司

Ropeginterferon alpha-2b Ropeginterferon alpha-2b + anti PD-1 KX01 TCRT PEG-GCSF PEG-cytokine X, Y Novel checkpoint Abs

駐台北印尼經濟貿易代表處

Indonesia Economic and Trade Office to Taipei is representative of Indonesia Government at Taiwan. Our main purpose is to promote Indonesia products and goods to Taiwan. The way we promote are through some programme like join exhibition, business matching, buying mission, and other activities. We are here to gain cooperation opportunities between Taiwan and Indonesia
|1|